by Jack Varon

1. Dixon TC, Meselson M, Guillemin J, Hanna PC. (1999) Anthrax. New England Journal of Medicine. 341: 815-826.
2. Shafazand S, Doyle R, Ruoss S, Weinacker A, Raffin TA. (1999) Inhalational Anthrax: Epidemiology, Diagnosis, and Management. Chest. 116: 1369-1376.
3. Van Ness GB. (1971) Ecology of Anthrax. Science. 172: 1303-1307.
4. Mock M, Fouet A. (2001) Anthrax. Annual Review of Microbiology. 55: 647-671.
5. Guidi-Rontani C, Weber-Levy M, Labruyere E, Mock M. (1999) Germination of Bacillus anthracis spores within alveolar macrophages. Molecular Microbiology. 31:9-17.
6. Grenha R, Rzechorzek NJ, Brannigan JA, de Jong RN, AB E, Diercks T, Truffault V, Ladds JC, Fogg MJ, Bongiorni C, Perego M, Kaptein R, Wilson KS, Folkers GE, Wilkinson AJ. (2006) Structural characterization of Spo0E-like Protein-aspartic acid phosphates that regulate sporulation in Bacilli. The Journal of Biological Chemistry. 281: 37993-38003.
7. Weiner MA, Hanna PC. (2003) Macrophage-mediated germination of bacillus anthracisendospores requires the gerH operon. Infection and Immunity. 71: 3954-3959.
8. Hanna PC, Acosta D, Collier RJ. (1993) On the role of macrophages in anthrax.  Proceedings of the National Academy of Science. 90: 10198-10201.
9. Fukao T. (2004) Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity. The Lancet Infectious Diseases. 4: 166-170.
10. Dixon TC, Fadl AA, Koehler TM, Swanson JA, Hanna PC. (2000) Early Bacillus anthracis-macrophage interactions: intracellular survival and escape. Cellular Microbiology. 2: 453-463.
11. Pickering AK, Osorio M, Lee GM, Grippe VK, Bray M, Merkel TJ. (2004) Cytokine response to infection with  Bacillus anthracis spores. Infection and Immunity. 72: 6382-6389.
12. Erwin JL, DaSilva LM, Bavari S, Little SF, Friedlander AM, Chanh TC. (2001) Macrophage-derived cell lines to not express proinflammatory cytokines after exposure to Bacillus anthracis Lethal Toxin. Infection and Immunity. 69:1175-1177.
13. Prince AS. (2003) The host response to anthrax lethal toxin: unexpected observations. The Journal of Clinical Investigations. 112: 656-658.
14. Moayeri M, Haines D, Young HA, Leppla SH. Bacillus anthracis lethal toxin induces TNF-a-independent hypoxia-mediated toxicity in mice. The Journal of Clinical Investigations. 112: 670-682.
15. Hoover DL, Friedlander AM, Rogers LC, Yoon IK, Warren RL, Cross AS. (1994). Anthrax edema toxin differentially regulated lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Infection and Immunity. 62: 4432-4439.
16. Hanna PC, Kruskal BA, Ezekowitz RA, Bloom BR, Collier RJ. (1994) Role of macrophage oxidative burst in the action of anthrax lethal toxin. Molecular Medicine. 1: 7-18.
17. Park JM, Greten FR, Li, ZW, Karin M. (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science. 297: 2048-2051.
18. Agrawal A, Lingappa J, Leppla SH, Agrawal S, Jabbar A, Quinn C, Pulendran B. (2003) Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature. 424: 329-334.
19. Turnbull PCB, Broster MG, Carman JA, Manchee RJ, Melling J. (1986). Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Infection and Immunity. 52: 356-363.
20. Fang H, Xu L, Chen TY, Cyr JM, Frucht DM. (2006) Anthrax lethal toxin has direct and potent inhibitory effects on B-cell proliferation and immunoglobin production. The Journal of Immunology. 176: 6155-6161.
21. Guidi-Rontani C, Dufolot E, Mock M. (1997) Anthrax lethal toxin-induced mitogenic response of human T-cells. FEMS Microbiology Letters. 157: 285-289.
22. Paccani SR, Tonello F, Patrussi L, Capitani N, Simonato M, Monteccco C Baldari CT. (2007) Anthrax toxins inhibit immune cell chemotaxis by perturbing chemomkine receptor signaling. Cellular Microbiology. 9: 924-929.
23. Paccani SR, Tonello F,  Ghittoni R, Natale M, Muraro L, D’Elios MM, Tang WJ, Montecucco C, Baldari CT. (2005) Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. Journal of Experimental Medicine. 201: 325-331.
24. Comer JE, Chopra AK, Peterson JW, Konig R. (2005) Direct inhibition of T lymphocyte activation by anthrax toxins in vivo. Infection and Immunity. 73: 8275-8281.
25. Ezzell Jr JW, Wlkos SL. (1999) The capsule of bacillus anthracis, a review. Journal of Applied Microbiology. 89: 250.
26. Escuyer V, Collier RJ. (1991) Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells. Infection and Immunity. 59: 3381-3386.
27. Little SF, Novak JM, Lowe JR, Leppla SH, Singh Y, Klimpel KR, Lidgerding BC, Friedlander AM. (1996) Characterization of lethal factor binding and cell receptor binding domains of protective antigen of bacillus anthracis using monoclonal antibodies. Microbiology. 142: 707-715.
28. Leppla SH. (1982) Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations in eukaryotic cells. Proceedings of the National Academy of Science. 79: 3162-3166.